{"id":"https://openalex.org/W4361950891","doi":"https://doi.org/10.1158/1078-0432.c.6521786.v1","title":"Data from Inhibition of DNA Double-Strand Break Repair by the Dual PI3K/mTOR Inhibitor NVP-BEZ235 as a Strategy for Radiosensitization of Glioblastoma","display_name":"Data from Inhibition of DNA Double-Strand Break Repair by the Dual PI3K/mTOR Inhibitor NVP-BEZ235 as a Strategy for Radiosensitization of Glioblastoma","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361950891","doi":"https://doi.org/10.1158/1078-0432.c.6521786.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6521786.v1","doi":"https://doi.org/10.1158/1078-0432.c.6521786.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6521786.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.c.6521786.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059504042","display_name":"Carlos Rodrigo Gil del Alcazar","orcid":"https://orcid.org/0000-0002-7167-1069","observed_orcids":["https://orcid.org/0000-0002-7167-1069"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carlos Rodrigo Gil del Alcazar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010310316","display_name":"Molly Catherine Hardebeck","orcid":"https://orcid.org/0009-0009-9641-7137","observed_orcids":["https://orcid.org/0009-0009-9641-7137"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Molly Catherine Hardebeck","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Bipasha Mukherjee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bipasha Mukherjee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009849862","display_name":"Nozomi Tomimatsu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nozomi Tomimatsu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110643528","display_name":"Xiaohuan Gao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaohuan Gao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114045838","display_name":"Jingsheng Yan","orcid":"https://orcid.org/0000-0002-3856-8019","observed_orcids":["https://orcid.org/0000-0002-3856-8019"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jingsheng Yan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101198644","display_name":"Xian-Jin Xie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xian-Jin Xie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044684517","display_name":"Robert M. Bachoo","orcid":"https://orcid.org/0000-0001-9229-9342","observed_orcids":["https://orcid.org/0000-0001-9229-9342"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Bachoo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100361259","display_name":"Li Li","orcid":"https://orcid.org/0000-0002-8630-3699","observed_orcids":["https://orcid.org/0000-0002-8630-3699"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Li Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014124937","display_name":"Amyn A. Habib","orcid":"https://orcid.org/0000-0003-4164-9028","observed_orcids":["https://orcid.org/0000-0003-4164-9028"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amyn A. Habib","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5069837318","display_name":"Sandeep Burma","orcid":"https://orcid.org/0000-0001-7057-9845","observed_orcids":["https://orcid.org/0000-0001-7057-9845"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandeep Burma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.8012999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.8012999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.12890000641345978,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.027499999850988388,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nvp-bez235","display_name":"NVP-BEZ235","score":0.9459999799728394},{"id":"https://openalex.org/keywords/pi3k-mtor-inhibition","display_name":"PI3K/mTOR inhibition","score":0.7480000257492065},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9269999861717224},{"id":"https://openalex.org/keywords/radiosensitization","display_name":"radiosensitization","score":0.9940000176429749},{"id":"https://openalex.org/keywords/double-strand-break-repair","display_name":"DNA double-strand break repair","score":0.9879999756813049},{"id":"https://openalex.org/keywords/dna-pkcs","display_name":"DNA-PKcs","score":0.8730000257492065},{"id":"https://openalex.org/keywords/ataxia-telangiectasia-mutated","display_name":"ATM kinase","score":0.902999997138977},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.8949999809265137},{"id":"https://openalex.org/keywords/ionizing-radiation","display_name":"ionizing radiation","score":0.968999981880188},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.9200000166893005},{"id":"https://openalex.org/keywords/chemosensitization","display_name":"chemosensitization","score":0.878000020980835},{"id":"https://openalex.org/keywords/orthotopic-glioma-model","display_name":"orthotopic glioma model","score":0.6690000295639038},{"id":"https://openalex.org/keywords/radioresistance-biology","display_name":"radioresistance (biology)","score":0.574999988079071}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7691766023635864},{"id":"https://openalex.org/C58962609","wikidata":"https://www.wikidata.org/wiki/Q2353022","display_name":"Radioresistance","level":3,"score":0.6242740750312805},{"id":"https://openalex.org/C68748289","wikidata":"https://www.wikidata.org/wiki/Q18030783","display_name":"DNA-PKcs","level":4,"score":0.6211206316947937},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.5827732682228088},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5244550704956055},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.4856318533420563},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.43014079332351685},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.4195299744606018},{"id":"https://openalex.org/C2776428644","wikidata":"https://www.wikidata.org/wiki/Q2126468","display_name":"Radiosensitizer","level":3,"score":0.41879206895828247},{"id":"https://openalex.org/C178169997","wikidata":"https://www.wikidata.org/wiki/Q2892636","display_name":"Genome instability","level":4,"score":0.41866534948349},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3937954306602478},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32491862773895264},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.29858824610710144},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.26221537590026855},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.2586330771446228},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.258497953414917},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.1900349259376526},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.13510075211524963},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.09065356850624084},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06786647439002991},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6521786.v1","doi":"https://doi.org/10.1158/1078-0432.c.6521786.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6521786.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6521786.v1","doi":"https://doi.org/10.1158/1078-0432.c.6521786.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6521786.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2161394680","https://openalex.org/W2329800827","https://openalex.org/W1963525125","https://openalex.org/W1926957395","https://openalex.org/W2741697185","https://openalex.org/W1967114760","https://openalex.org/W2806214588","https://openalex.org/W2107368898","https://openalex.org/W2147169705","https://openalex.org/W2035508274"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Inhibitors":[2],"of":[3,14,109,161,176,193,214,230],"the":[4,49,58,127,174,191,228],"DNA":[5,31,179,254],"damage":[6,180],"response":[7],"(DDR)":[8],"have":[9,38],"great":[10],"potential":[11,93],"for":[12,151,227],"radiosensitization":[13],"numerous":[15],"cancers,":[16],"including":[17],"glioblastomas,":[18],"which":[19,189],"are":[20,29],"extremely":[21],"radio-":[22,96],"and":[23,69,84,90,97,119,133,149,153,159,169,172,252],"chemoresistant":[24],"brain":[25,194,207],"tumors.":[26,182],"Currently,":[27],"there":[28],"no":[30],"double-strand":[32],"break":[33],"(DSB)":[34],"repair":[35,157,175,255],"inhibitors":[36,256],"that":[37,48,236],"been":[39],"successful":[40],"in":[41,73,86,88,99,117,136,181,185],"treating":[42],"glioblastoma.":[43,231],"Our":[44],"laboratory":[45],"previously":[46],"demonstrated":[47],"dual":[50],"phosphoinositide":[51],"3-kinase/mTOR":[52],"inhibitor":[53],"NVP-BEZ235":[54,79,110,148,164,209],"can":[55],"potently":[56,165],"inhibit":[57,82],"two":[59],"central":[60],"DDR":[61],"kinases,":[62],"DNA-dependent":[63],"protein":[64],"kinase":[65],"catalytic":[66],"subunit":[67],"(DNA-PKcs)":[68],"ataxia-telangiectasia":[70],"mutated":[71],"(ATM),":[72],"vitro.":[74],"Here,":[75],"we":[76],"tested":[77,112],"whether":[78],"could":[80],"also":[81,210],"ATM":[83,154,170],"DNA-PKcs":[85,152,168],"tumors":[87,140,198,216],"vivo":[89],"assessed":[91],"its":[92],"as":[94,258],"a":[95,200,212,219],"chemosensitizer":[98],"preclinical":[100],"mouse":[101],"glioblastoma":[102,121,244],"models.":[103,122],"Experimental":[104],"Design:":[105],"The":[106],"radiosensitizing":[107],"effect":[108],"was":[111],"by":[113,246],"following":[114],"tumor":[115,187],"growth":[116],"subcutaneous":[118,215],"orthotopic":[120],"Tumors":[123],"were":[124,141],"generated":[125],"using":[126],"radioresistant":[128],"U87-vIII":[129],"glioma":[130],"cell":[131],"line":[132],"GBM9":[134],"neurospheres":[135],"nude":[137],"mice.":[138,196],"These":[139,233],"then":[142],"treated":[143],"with":[144,205,224,250],"ionizing":[145,177,225,248],"radiation":[146,226,249],"and/or":[147],"analyzed":[150],"activation,":[155],"DSB":[156],"inhibition,":[158],"attenuation":[160],"growth.":[162],"Results:":[163],"inhibited":[166],"both":[167],"kinases":[171],"attenuated":[173],"radiation\u2013induced":[178],"This":[183],"resulted":[184],"striking":[186],"radiosensitization,":[188],"extended":[190],"survival":[192],"tumor\u2013bearing":[195],"Notably,":[197],"displayed":[199],"higher":[201],"DSB-load":[202],"when":[203],"compared":[204],"normal":[206],"tissue.":[208],"sensitized":[211],"subset":[213],"to":[217,241],"temozolomide,":[218],"drug":[220],"routinely":[221],"used":[222],"concurrently":[223],"treatment":[229],"Conclusions:":[232],"results":[234],"demonstrate":[235],"it":[237],"may":[238],"be":[239],"possible":[240],"significantly":[242],"improve":[243],"therapy":[245],"combining":[247],"potent":[251],"bioavailable":[253],"such":[257],"NVP-BEZ235.":[259],"Clin":[260],"Cancer":[261],"Res;":[262],"20(5);":[263],"1235\u201348.":[264],"\u00a92013":[265],"AACR.":[266]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}